The tissue-engineered heart valve portends a new era in the field of valve replacement. Decellularized heart valves are of great interest as a scaffold for the tissue-engineered heart valve due to their naturally bioactive composition, clinical relevance as a stand-alone implant, and partial recellularization in vivo. However, a significant challenge remains in realizing the tissue-engineered heart valve: assuring consistent recellularization of the entire valve leaflets by phenotypically appropriate cells. Many creative strategies have pursued complete biological valve recellularization; however, identifying the optimal recellularization method, including in situ or in vitro recellularization and chemical and/or mechanical conditioning, ha...
The multidisciplinary research of tissue engineering utilizes biodegradable or decellularized scaffo...
To date an optimal decellularization protocol of heart valve leaflets (HVL) and pericardia (PER) wit...
Richard Hopkins of Brown University presented a lecture on October 14, 2003 at 3:00 pm in the Suddat...
The overall objective of this thesis was to fill critical knowledge gaps for the development of the ...
Decellularized xenogenic or allogenic heart valves have been used as starter matrix for tissue-engin...
The Tricuspid Heart Valve is composed of three leaflets: the anterior leaflet, posterior leaflet, an...
Tissue engineered valves have the potential of being an ideal valve substitute for transplants, as ...
Heart valve replacement represents the most common surgical therapy for end-stage valvular heart dis...
Background: Heart valve tissue engineering represents a concept for improving the current methods of...
Heart valve tissue engineering based on decellularized xenogenic or allogenic starter matrices has s...
Background: Heart valve disease is a clinically serious condition. The replacement of damaged valves...
Current research on valvular heart repair has focused on tissue-engineered heart valves (TEHV) becau...
The quest for the ideal heart valve replacement is ongoing as current substitutes, such as mechanica...
Background— Tissue engineering represents a promising approach for the development of living heart v...
The multidisciplinary research of tissue engineering utilizes biodegradable or decellularized scaffo...
To date an optimal decellularization protocol of heart valve leaflets (HVL) and pericardia (PER) wit...
Richard Hopkins of Brown University presented a lecture on October 14, 2003 at 3:00 pm in the Suddat...
The overall objective of this thesis was to fill critical knowledge gaps for the development of the ...
Decellularized xenogenic or allogenic heart valves have been used as starter matrix for tissue-engin...
The Tricuspid Heart Valve is composed of three leaflets: the anterior leaflet, posterior leaflet, an...
Tissue engineered valves have the potential of being an ideal valve substitute for transplants, as ...
Heart valve replacement represents the most common surgical therapy for end-stage valvular heart dis...
Background: Heart valve tissue engineering represents a concept for improving the current methods of...
Heart valve tissue engineering based on decellularized xenogenic or allogenic starter matrices has s...
Background: Heart valve disease is a clinically serious condition. The replacement of damaged valves...
Current research on valvular heart repair has focused on tissue-engineered heart valves (TEHV) becau...
The quest for the ideal heart valve replacement is ongoing as current substitutes, such as mechanica...
Background— Tissue engineering represents a promising approach for the development of living heart v...
The multidisciplinary research of tissue engineering utilizes biodegradable or decellularized scaffo...
To date an optimal decellularization protocol of heart valve leaflets (HVL) and pericardia (PER) wit...
Richard Hopkins of Brown University presented a lecture on October 14, 2003 at 3:00 pm in the Suddat...